The drug "Avifavir" at the end of May passed clinical trials and showed its effectiveness in the fight against coronavirus. After the registration certificate of the Ministry of Health was received, the Russian medicine became the first drug on the market against coronavirus. The main active ingredient in tablets is favipiravir.
“Given the decision of the US authorities to purchase almost 100% of the manufactured Remdesivir (Gilead Sciences) in the coming months and the shortage of effective drugs on the world market, Russia is ready to help other countries in the fight against coronavirus and begin foreign supplies of Avifavir. The Russian drug is several times cheaper, while the form of release in tablets simplifies its administration, allowing therapy at the early stages of infection with coronavirus, ”explained the head of the RDIF Kirill Dmitriev in a message. Also, soon the drug will begin to be delivered to Kazakhstan.
Initially, the companies planned to produce 60 thousand courses, but already in July they managed to produce 100 thousand drugs. Then the production capacity was further increased, and now it is expected that the company will be able to produce up to 300 thousand courses of the drug per month. This will expand the list of countries for export. Earlier, the WHO international organization said that 140 coronavirus vaccines are being developed in the world.